Literature DB >> 19084945

Intraoperative pulmonary hypertension occurred in an asymptomatic patient with pre-existent liver cirrhotic and portal hypertension.

Ling Lu1, Feng Zhang, Xiang-Cheng Li, Guo-Qiang Li, Chuan-Yong Zhang, Xue-Hao Wang.   

Abstract

Portopulmonary hypertension (PPH) is clinically defined as the development of pulmonary arterial hypertension complicated by portal hypertension, with or without advanced hepatic disease. Physical signs may be absent in mild to moderate PPH and only appear in a hyperdynamic circulatory state. Similar signs of advanced liver disease can be observed in severe PPH, with ascites and lower extremity edema. Pulmonary hypertension is usually diagnosed after anesthetic induction during liver transplantation (LT). We present intraoperative pulmonary hypertension in a 41-year-old male patient with hepatic cirrhosis. Since this patient had no preoperation laboratory data supporting the diagnosis of pulmonary hypertension and was asymptomatic for a number of years, it was necessary to send him to the intensive care unit after operation. Further study should be focused on the diagnosis and treatment of pulmonary arterial hypertension in order to reduce its mortality.

Entities:  

Mesh:

Year:  2008        PMID: 19084945      PMCID: PMC2776888          DOI: 10.3748/wjg.14.7260

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

Review 1.  Some aspects of circulatory disturbances in cirrhosis of the liver.

Authors:  G A Martini; G Baltzer; H Arndt
Journal:  Prog Liver Dis       Date:  1972

2.  Distinctive clinical features of portopulmonary hypertension.

Authors:  P C Kuo; J S Plotkin; L B Johnson; C D Howell; J M Laurin; S T Bartlett; L J Rubin
Journal:  Chest       Date:  1997-10       Impact factor: 9.410

3.  Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: a safe and effective therapy?

Authors:  Christian Kuntzen; Veit Gülberg; Alexander L Gerbes
Journal:  Gastroenterology       Date:  2005-01       Impact factor: 22.682

4.  Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol.

Authors:  A L Rafanan; J Maurer; A C Mehta; R Schilz
Journal:  Chest       Date:  2000-11       Impact factor: 9.410

5.  New predictors of outcome in idiopathic pulmonary arterial hypertension.

Authors:  Steven M Kawut; Evelyn M Horn; Ketevan K Berekashvili; Robert P Garofano; Rochelle L Goldsmith; Allison C Widlitz; Erika B Rosenzweig; Diane Kerstein; Robyn J Barst
Journal:  Am J Cardiol       Date:  2005-01-15       Impact factor: 2.778

6.  Emergency adult living donor right lobe liver transplantation for fulminant hepatic failure.

Authors:  Feng Zhang; Xuehao Wang; Xiangcheng Li; Lianbao Kong; Beicheng Sun; Guoqiang Li; Xiaofen Qian; Feng Chen; Ke Wang; Sheng Lu; Liyong Pu; Ling Lu
Journal:  Front Med China       Date:  2007-07-01

7.  Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database.

Authors:  Michael J Krowka; M Susan Mandell; Michael A E Ramsay; Steve M Kawut; Michael B Fallon; Cosme Manzarbeitia; Manuel Pardo; Paul Marotta; Shinji Uemoto; Markus P Stoffel; Joanne T Benson
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

8.  Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension.

Authors:  Giovanni L Ricci; Maria Teresa Melgosa; Felip Burgos; José Luis Valera; Sandra Pizarro; Josep Roca; Roberto Rodriguez-Roisin; Joan Albert Barberà
Journal:  Liver Transpl       Date:  2007-11       Impact factor: 5.799

9.  Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease.

Authors:  R B Himelman; M Stulbarg; B Kircher; E Lee; L Kee; N C Dean; J Golden; C L Wolfe; N B Schiller
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

10.  De novo diagnosis of portopulmonary hypertension following liver transplantation.

Authors:  Baburao Koneru; Adrian Fisher; Dorian J Wilson; Kenneth M Klein; Andrew N delaTorre; Joseph Seguel
Journal:  Am J Transplant       Date:  2002-10       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.